Susquehanna Fundamental Investments, LLC Chembio Diagnostics, Inc. Transaction History

Susquehanna Fundamental Investments, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.35 - $1.1 $62,096 - $195,160	-177,419 Reduced 85.95%	29,000 $10,000
Q1 2022 May 16, 2022	SELL	$0.66 - $1.23 $1,492 - $2,781	-2,261 Reduced 1.08%	206,419 $169,000
Q4 2021 Feb 14, 2022	BUY	$1.09 - $2.55 $31,610 - $73,950	29,000 Added 16.14%	208,680 $238,000
Q3 2021 Nov 15, 2021	BUY	$2.06 - $5.34 $370,140 - $959,491	179,680 New	179,680 $449,000
Q2 2021 Aug 11, 2021	SELL	$2.88 - $5.64 $59,616 - $116,748	-20,700 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$3.4 - $7.97 $10,047 - $23,551	-2,955 Reduced 12.49%	20,700 $73,000
Q4 2020 Feb 16, 2021	SELL	$4.11 - $7.51 $175,032 - $319,828	-42,587 Reduced 64.29%	23,655 $112,000
Q3 2020 Nov 16, 2020	BUY	$3.28 - $5.93 $124,777 - $225,589	38,042 Added 134.9%	66,242 $322,000
Q2 2020 Aug 14, 2020	BUY	$3.18 - $15.54 $89,676 - $438,228	28,200 New	28,200 $92,000

Ticker CEMI
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,224,600
Description
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.